Introduction
One of the currently best characterized chemokine (Chemotactic cytokine) is the monocyte-chemoattractant protein-1 (MCP-1) (Rollins et al., 1989) , which triggers the in®ltration and activation of cells of the monocyte-macrophage lineage, representing known producers of growth-modulatory cytokines (Miller and Krangel, 1992) . Synthesis of cytokines can be considered as an important regulatory loop in the immunological surveillance, since TNF-a or TGF-b can negatively interfere with the expression of high risk human papillomaviruses (HPV) types (Majewski et al., 1996; Ozbun and Meyers, 1996) , the causative agents of cancer of the cervix uteri (for review, see zur . Besides disturbance of a functional Tcell surveillance (Altmann et al., 1994) , dys-regulation of chemokine expression may represent another important counter-selection event during the multi-step progression to cervical cancer . Consistent with this anticipation was the recent ®nding that MCP-1 expression indeed gradually disappears in dierent stages of premalignant cervical intraepithelial neoplasias , a process, which may explain the severe reduction of intraepithelial macrophages (Tay et al., 1987) and Langerhans'cells (Spinillo et al., 1993) .
To understand the regulation of the human MCP-1 gene in correlation with malignancy, we took advantage of a somatic cell hybrid system which allows the investigation of chemokine expression in HPV-positive cells, diering in their tumorigenic potential in immunocompromised animals (Stanbridge, 1984) . In highly tumorigenic HPV 18-positive cervical carcinoma cell line HeLa, MCP-1 expression is not detectable under Northern blot hybridization conditions. MCP-1 expression and TNF-a inducibility, however, can be completely restored in non-tumorigenic hybrids obtained after fusion of HeLa cells with normal primary human ®broblasts. On the other hand, MCP-1 transcription is again abolished in malignant segregants derived from the very same hybrids, strongly suggesting a correlation between absence of chemokine transcription and tumorigenicity .
To gain insight into the dierential expression and TNF-a inducibility of the MCP-1 gene, we continued our previous studies Kleine et al., 1995; Kleine-Lowinski et al., 1999) in determining the position of nuclease hypersensitive regions in native chromatin, which are known hallmarks for regulatory elements on DNA level (Felsenfeld, 1992) . Using this experimental approach, it was possible to show that the functionality of MCP-1 transcription is based on structural dierences in position, size and distribution of hypersensitive regions (DHSRs) not only at the 5'-, but also at the 3'-end of the gene. The 3'-regulatory region, whose chromatin structure becomes strongly opened after treatment with TNF-a in non-tumorigenic hybrids revealed the presence of an additional 3'-located AP-1 site. Analysing the AP-1 composition, we found that MCP-1 expression and TNF-a inducibility occurred only in those cells, where members of the junfamily (e.g. c-jun) were mainly dimerized with the fosrelated protein fra-1.
Results
Selective MCP-1 inducibility by TNF-a: demonstration of the integrity of the TNF-a signal transduction pathway in malignant and non-malignant HPV 18-positive cells Monitoring the expression of the MCP-1 gene in HPV 18 positive cells diering in their potential to form tumors in nude mice (Stanbridge, 1984) , MCP-1 was transcribed and TNF-a inducible only in non-malignant hybrids made between HeLa cervical carcinoma cells and normal human ®broblasts (Figure 1a , designated as`444'). In contrast, examination of either the tumorigenic segregants from the same hybrids (designated as`CGL3') or the parental tumorigenic HeLa cells showed the complete absence of detectable transcripts under the same experimental conditions . The intensity of the MCP-1 mRNA reached a maximum 5 h after TNF-a addition and declined to almost baseline level 18 h after TNF-a treatment. The absence of MCP-1 inducibility in the tumorigenic cells cannot be attributed to disturbances in the cytokine signal transduction pathway, since the simultaneous application of TNF-a and a protein synthesis inhibitor (cycloheximide) for 4 h induced blebbing of the cellular membrane (Figure 1b) , a morphological feature characteristic for TNF-a mediated apoptosis (Cohen, 1993) . The extend of apoptosis was quanti®ed using a cell death detection ELISA kit which determine the amount of free histones within the cytoplasmic fraction after nuclear envelope breakdown and DNA fragmentation into discrete multiplicities of mononucleosomes. (Figure  1c ). The integrity of the TNF-a pathway was further con®rmed by the rapid proteolysis (after 30 min) and delayed re-synthesis (after 5 h) of the inhibitory component IkB-a (Figure 1d ), leading to the activation of the transcription factor NF-kB (Henkel et al., 1993) .
MCP-1 mRNA expression is regulated at the level of initiation of transcription: nuclear run-on assays In order to address the question of whether the restricted expression of MCP-1 and its TNF-a inducibilitity in non-tumorigenic cells was due to a transcriptional block, nuclear run-on experiments were carried out. Hybridization of equal counts of 32 P-UTP labeled total RNA to de®ned amounts of immobilized DNA showed the absence of MCP-1 expression in TNF-a treated tumorigenic`CGL3' cells, while the gene became strongly induced in`444' cells 5 h after TNF-a addition (Figure 2 ). The induction was selective, which was con®rmed by a direct comparison with the degree of transcriptional activity of other reference genes such as HPV 18 or b-actin. Furthermore, loading a small amount of total cellular DNA on nitrocellulose strips demonstrated that the total 32 P-UTP incorporation of the nascent RNA was the same. These data indicate that TNF-a mediated MCP-1 induction is regulated at the level of initiation of 5 cells were incubated in the presence of 250 U/ ml of TNF-a for 5 and 18 h, respectively. 5 mg RNA of each HeLa cells, non-tumorigenic HeLa-®broblast hybrids (`444') and their tumorigenic segregants (`CGL3') was separated in a 1% agarose gel. After blotting, the ®lter was consecutively hybridized with cDNA probes encoding the MCP-1 and the b-actin gene. c, e) or after simultaneous incubation with TNF-a (500 U/ml) and cycloheximide (10 mg/ml) for 4 h at 378C. Phase-contrast microscopy (Magni®cation: 1006). (c) Quanti®cation of apoptosis after treatment with TNF-a/CHX (see b) using a commercially available cell death detection ELISA kit (Roche). The enrichment factor, for untreated control cells arbitrarily set as 1, directly re¯ects the extent of apoptosis. (d) Degradation and re-synthesis of IkB-a after treatment of HeLa-,`444'-, and`CGL3'-cells with 250 U/ml TNF-a for 30 min (min) or 5 h (h). 30 mg total cellular protein was separated in a 12% SDS ± PAGE gel for Western blot analysis. After electrotransfer, the ®lter was probed with a polyclonal antibody directed against IkB-a. To con®rm equal loading, an identical ®lter was incubated with a b-actin speci®c antibody transcription rather than by post-transcriptional mechanisms.
Mapping of DNAse I hypersensitive regions (DHSRs) at the 5'-and 3'-end of the MCP-1 gene in native chromatin: evidence for a novel TNF-a inducible DHSR at the 3'-end
In order to obtain more information on MCP-1 transcriptional regulation, the chromatin structure of the whole MCP-1 locus was examined. As shown in Figure 3a , there is one major DNAse I hypersensitive region (DHSR) in`444'-cells, whose maximum DNAse I cutting frequency was located approximately 2.4 ± 2.9 kb upstream of the KpnI site (position +211/+216 relative to the transcriptional start site; see Ueda et al., 1994) . In contrast, the major DHSR visible in`CGL3' cells, has a smaller extension only ranging from 2.7 ± 2.9 kb (Figure 3b ). In addition, the 5'-chromatin structure in`444'-cells revealed the presence of two minor DHSRs (see schematic presentation below): a distal and a proximal one, located 5.1 and 1.5 kb, respectively, upstream of the KpnI site (for DNA sequence analysis, see Figure 6 ).
Taking advantage that the restriction endonuclease DraI is located not only within the minor distal DHSR (position 71259/71254) but also at the 3'-boundary of the major`444'-DHSR (position 72186/72191, see also Figure 6 ), incubation of isolated nuclei with DraI provides additional evidence for the larger size and higher TNF-a mediated susceptibility of this chromatin stretch in non-malignant cells. As shown in Figure 4a , digestion of`444' derived nuclei led to a fast and strong appearance of two DraI-derived subfragments (2.4 and 1.5 kb, respectively), whose intensity were even pronounced after TNF-a application. Quantifying the resulting sub-bands relative to the intensity of the undigested parental 7.7 kb fragment showed that already a 15 min incubation with 25 units of DraI was sucient to cleave almost 45% of the chromatin (corresponding to 100 mg DNA) (data not shown). In contrast, the same region was much more resistant in untreated`CGL3' control cells (Figure 4a ). Accessibility to DraI was only weakly elevated by TNF-a (accumulation of the cleaved sub-bands increased from 6 to 12% relative to the parental fragment; data not shown), unequivocally demonstrating a dierent degree of chromatin decondensation in both cell lines. Treating the same nuclei with ApaI (position 72692/ 72697), a restriction endonuclease which is located directly within the major 5'-DHSRs in both cell lines, no dierences in the temporal appearance and the intensity of the generated sub-bands could be observed ( Figure 4b ).
Mapping of the 3'-region of the MCP-1 gene resulted in a completely dierent picture. In contrast to the preexisting major 5'-DHSR, which was only slightly induced upon TNF-a application (Figure 3a and b), cytokine treatment led to a strong appearance of a prominent 3'-DHSR, which is located between 2.7 ± -+ -+ Figure 2 Nuclear run-on analysis. Ongoing transcription from TNF-a treated (250 U/ml, for 5 h) and control nuclei was examined by hybridizing equal counts of 32 P-UTP nascent RNA to nitrocellulose strips carrying the same amount of heatdenaturated DNA probes (2.5 mg of MCP-1, HPV 18, b-actin and p`Bluescript' plasmid DNA). To con®rm identical hybridization conditions, 50 ng of total cellular DNA was loaded as an internal reference. (7): untreated cells; (+): cells incubated with 250 U/ml of TNF-a Figure 3 DNAse I mapping analysis of the 5'-regulatory region. 444' (a) and`CGL3' cells (b) were treated for 5 h with TNF-a (250 U/ml). Isotonic nuclei equivalent to 100 mg of total DNA from either untreated or TNF-a treated cells were subsequently digested with increasing amounts of DNAse I (1.0; 2.0; 3.0; 4.0; and 5.0 units of DNAse I/100 ml volume) for 5 min at 378C. After extraction, the DNAs were cleaved with KpnI, separated on 1% agarose gels and hybridized with a cloned PCR fragment located adjacent to KpnI (positions 7539 to +52 relative to the transcriptional start site de®ned by Ueda and co-workers (Ueda et al., 1994) for indirect-end-labeling. The length of the subbands generated after DNAse I-KpnI digestion is indicated in kb.`Cont 1': nuclei lysed immediately after preparation;`Cont 2': DNA from nuclei incubated in digestion buer without DNAse I. The schematic presentation below shows the location of the major and minor DNAse I hypersensitive regions (DHSR) relative to the KpnI site (position +211/+216) in both cell lines (indicated by an arrow). The length of the parental 7.7 kb KpnI-KpnI fragment and the position of hybridization probe (`probe') are indicated Furthermore, TNF-a kinetics and subsequent DNAse I mapping analyses indicated that DHSR con®guration even slightly preceded MCP-1 induction (data not shown), suggesting that changes in the nucleosomal organization was a requisite rather than a consequence of TNF-a mediated MCP-1 transcription. Carrying out the same experimental approach for both the tumorigenic segregants (Figure 5b ) or the parental HeLa cells (data not shown), no 3'-DHSR could be detected. One can therefore conclude that the dierences of MCP-1 transcription and TNF-a inducibility in tumorigenic and non-tumorigenic HPV-positive cells is obviously mediated by a concerted action of at least two dierent (7) and TNF-a treated (250 U/ml, for 5 h)`444'-and`CGL3' cells were digested with increasing amounts of DraI (25 and 50 units for 15 min at 378C). After restriction enzyme digestion, the DNAs were processed as described in Figure 3 .`Cont': DNA from nuclei incubated in digestion buer for 15 min at 378C without any enzyme. The schematic presentation shows the length and the derivation of the subbands generated after DraI-KpnI cleavage (for details, see Figure 3 ). (b) Same as (a), only after treatment of the nuclei with ApaI restriction endonuclease Figure 5 DNAse I mapping analysis of the 3'-regulatory region. 444' (a) and`CGL3' cells (b) were treated with TNF-a as descibed in Figure 3 . Nuclei corresponding to 100 mg of total DNA obtained from untreated and cytokine treated cells were digested with increasing amounts of DNAse I (1.0; 2.0; 3.0; 4.0; and 5.0 units of DNAse I/100 ml volume) for 5 min at 378C. After lysis, the puri®ed DNAs were cleaved with HindIII, separated on 1% agarose gels and hybridized with a cloned PCR fragment (position 7539 to +52 relative to the transcriptional start site) located adjacent to the HindIII site for indirect-end-labeling. The length of the subbands generated after DNAse I-HindIII digestion is indicated in kb.`Cont 1': nuclei lysed immediately after preparation.`Cont 2': DNA from nuclei incubated in digestion buer without adding enzyme. The schematic presentation below shows the location (indicated by an arrow) of the major and minor DNAse I hypersensitive regions (DHSR) relative to the HindIII site (position 7428/7423). The length of the parental 4.7 kb HindIII-HindIII fragment, the position of hybridization probe (`probe'), the three exons (`Exon I-III') and the location of the chemokine speci®c polyadenylation signal (`poly-A') are indicated regulatory regions. One is located at the 5'-end, being characterized by their higher complexity in terms of location and distribution of DHSRs; the other is situated approximately 600 bp downstream of the MCP-1 speci®c polyadenylation signal within a 3'-regulatory domain, whose chromatin structure only became accessible after cytokine treatment.
DNA sequencing and band-shift analysis: detection of a novel AP-1 site within the 3'-DNAse I hypersensitive region
Since the MCP-1 gene is located at chromosome 17 (Mehrabian et al., 1991) , we screened a chromosomespeci®c library to isolate the whole genomic locus of the human MCP-1 gene using the corresponding cDNA (Rollins et al., 1989 ) and a PCR ampli®ed promoter fragment as hybridization probe. DNA sequence analysis essentially con®rmed the sequence data of the 3.8 kb upstream region published by Ueda and co-workers (Ueda et al., 1994) (see also Figure 6 ). Single nucleotide variations may be dependent on dierent origins of the clones used for sequencing. Inspecting the nucleotide sequence surrounding the minor 5'-DHSR 1.5 kb upstream of the KpnI site, a putative NF-IL-6 (C/EBP-b) consensus sequence was found ( Figure 6 ). Similar sequences could be detected within the minor 2.0 kb subfragment and the major 3'-end DHSR 2.7 ± 3.4 bp subfragments (see Figure 6 ). Band-shift analysis of designed oligonucleotides however, failed to reveal any signi®cant binding (data not shown). This was in marked contrast to the nucleotide stretch covered by the major DHSR in native`444'-chromatin, where two contiguous NF-kB sites and one AP-1 site could be detected (Figure 6 ). Since all three cis-regulatory sequences were already shown to be functional in DNA binding assays (Ueda et al., 1994 (Ueda et al., , 1997 , they were not further followed up in this study. Both the distal 5.1 kb and the proximal 1.5 kb minor 5'-DHSRs coincide with putative consensus sequences for the transcription factor Sp1, previously claimed to play a role in the maintenance of basal MCP-1 transcription (Ueda et al., 1994 (Ueda et al., , 1997 .
Scanning the 3'-end for potential regulatory sequences, an additional downstream AP-1 site (5'-TGAGTCA-3', position +2594/+2600) ( Figure 6 ) could be detected. To prove the functionality of this sequence in terms of DNA binding, electrophoretic band-shift assays were performed. Using the oligonucleotide 5'-GGAAGGTTGAGTCAAGGGATT-3' (position +2587/+2607), a single band can be visualized after incubation with a nuclear extract obtained from 444'-cells (Figure 7a, lane 1) . The speci®city of AP-1 binding was con®rmed in competition experiments by adding a 100-fold molar unlabeled excess of either the homologous (Figure 7a , lane 2,`hom. comp. AP-1 3'') or a oligonucleotide containing the AP-1 site (lane 4; comp. AP-1 consensus') of the collagenase TPA responsive element (Lee et al., 1987) , leading in both cases to complete disappearance of the 3'-AP-1 retarded band. No competition, however, could be achieved, when a heterologous, nuclear factor 1 (`NF-1') speci®c oligonucleotide ( Figure 7a, lane 3; hetero. Comp. NF-1) (Kenny and Hurwitz, 1988) was applied. In order to discern whether or not the extent of AP-1 binding is dierent between`444'-and`CGL3'-cells and whether the anity was modulated by TNF-a, we analysed the binding properties of dierent extracts in Figure 6 Nucleotide sequence analysis of the 5'-and 3'-regulatory region of the human MCP-1 gene covered by DNAse I hypersensitive regions (DHSRs) in native chromatin. Nucleotide numbering was done relative to the transcriptional start site (Ueda et al., 1994) . Some DHSRs coincide with a DNA fragment already shown to harbor functional binding sites for the transcription factors AP-1 and NF-kB (see nucleotide stretch ranging from position 72799 to 7300, Ueda et al., 1994) (Figure 7b ). Although CGL3' cells lack MCP-1 expression (see Figures 1  and 2 ), all nuclear extracts showed identical binding anity independently of whether the cells were treated with TNF-a or not prior to cell harvesting (Figure 7b , lanes 1 ± 4). The absence of enhanced AP-1 binding was not an exceptional feature of the 3'-AP-1 site, because the anity to the collagenase speci®c site was also not signi®cantly altered. (Figure 7b , lanes 5 and 6). Since we previously demonstrated that the composition of AP-1 diers considerably with respect to the jun/fos and the jun/fra-1 ratio in tumorigenic and nontumorigenic cells (Soto et al., 1999 (Soto et al., , 2000 , band-shift assays in combination with speci®c antibodies raised against AP-1 family members were carried out.
As illustrated in Figure 8a , addition of a c-jun antibody resulted in a strong super-shift indicating that there exists substantial amounts of c-jun homo-and heterodimers in both cell lines (Figure 8a , lanes 2 and 6). A completely dierent situation, however, was obtained when antibodies raised against fra-1 were added after the binding reaction. In`444'-cells, most (50%) of jun-family members (e.g. c-jun) were mainly heterodimerized with the fos-related protein fra-1 (Figure 8a, lane 4) , while in tumorigenic`CGL3'-cells only approximately 15% of the radioactivity (as determined by quanti®cation of the radioactivity in à PhosphoImager') was retarded within the super-shift complex (Figure 8a, lane 8) . Conversely, AP-1 iǹ CGL3'-cells contain c-fos (between 5 ± 7%) (Figure 8a , Figure 7 Band-shift analysis of the 3'AP-1 site within the major DHSR. (a) 2.5 mg`444' extract was incubated with a 32 P-labeled oligonucleotide from positions +2587/+2607. (referred as AP-1 (3'), see schematic presentation depicted below). Lane 1: without competition; lane 2: addition of a 100-fold molar excess of unlabeled homologous oligonucleotides (`hom. comp. AP-1 3''); lane 3: addition af a 100-fold molar excess of an oligonucleotide harboring a recognition site for the transcription factor NF-1 (`hetero. comp. NF-1'); lane 4: competition with a 100-fold excess of an oligonucleotide containing an AP-1 site of the human collagenase gene (`hom. comp. consensus'). (b) (Lanes 1 ± 4) bandshift analysis using the AP-1 3'-oligonucleotide (`AP-1 3'-end') after incubation with nuclear extracts derived from control (7) and TNF-a treated (+)`444'-and`CGL3' cells. Lanes 5 and 6: band-shift pattern of an AP-1 oligonucleotide from the human collagenase gene (`AP-1 consens.') using either`444'-or`CGL3' nuclear extracts. Cells were treated with TNF-a (250 U/ml) for 5 h. The position of the AP-1 speci®c DNA-protein complex is indicated. The schematic presentation below shows the location and sequence of the 3'-AP-1 site within the 3'-major DHSR relative to the genome organization of the MCP-1 gene Figure 8 (a) Supershift-analysis of the AP-1 complex in`444' and`CGL3' cells. 32 P-labeled AP-1 speci®c oligonucleotides derived from the 3'-DHSR (referred as`AP-1 3'-end') were incubated with nuclear extracts from`444'-and`CGL3'-cells either in the absence (7) (lanes 1 and 5) or in the presence of speci®c antibodies raised against c-jun (lanes 2 and 6), c-fos (lanes 3 and 7) or fra-1 (lanes 4 and 8) . The arrowhead marks the position of the retarded`super-shift' complexes. (b) Selective induction of the human type I collagenase gene in`444' cells after TNF-a treatment (250 U/ml) for 30 min (30'), 4 and 8 h. RNA was extracted and monitored by Northern blot analysis. The same ®lter was consecutively hybridized with a cDNA probe homologous to the human collagenase and the b-actin gene. The ethidium bromide stained gel shows the integrity and the position of the 28S and 18S rRNA. (7): untreated control cells lane 7), which is not detectable in non-malignant`444'-cells (Figure 8a, lane 3) , even after prolonged exposure to the autoradiography. EMSA supershift pattern was not signi®cantly altered after TNF-a addition (data not shown). To unequivocally demonstrate a dierent functionality of the transcription factor AP-1 upon cytokine addition in our experimental cell system, we examined the expression of a marker gene which is known to be tightly regulated by AP-1 (Angel and Karin, 1991). As already shown for MCP-1 (Figure  1a) , treatment with TNF-a resulted in a strong induction of the type I collagenase exclusively iǹ 444'-cells, while the gene was transcriptionally silent in the tumorigenic segregants of the same hybrids (`CGL3') or in the parental HeLa cells (Figure 8b ).
Discussion
The aim of the present study was to understand the dierential transcriptional regulation of the human monocyte-chemoattractant protein-1 (MCP-1) gene in malignant and non-malignant HPV 18 positive cells (Figure 1a ). This could be an important aspect during HPV-linked carcinogenesis, since dys-regulation in MCP-1 expression may provide a selective growth advantage of HPV-positive cells by abrogating the chemotactic in®ltration of growth-inhibitory cytokinesecreting macrophages KleineLowinski et al., 1999) . As shown in Figure 1 , the restricted induction of MCP-1 in non-tumorigenic HeLa-®broblast hybrids was not merely due to a de®ciency in the TNF-a signal transduction, since a combined treatment of TNF-a with cycloheximide resulted in apoptosis, independently of whether the MCP-1 gene was expressed or not (Figure 1b and c) . Moreover, the rapid decay and re-synthesis of IkB-a further substantiated the functionality of the TNF-a pathway in all cell lines (Figure 1d ), because the temporal degradation of IkB-a is one necessary step in the activation and translocation of the transcription factor NF-kB into the nucleus (Henkel et al., 1993) .
Considering the transcriptional regulation of many proin¯ammatory cytokines, dierent levels of control are conceivable: one is acting on the half-life of the corresponding mRNAs via labilization of A/U-rich elements located in the 3'-untranslated region (for review, see Jackson, 1993) . The other mechanism, which has been reported recently for the lipopolysaccharide-induced expression of the TNF-a gene (Biragyn and Nedosparsov, 1995) , controls the processing of freshly synthesized transcripts by premature termination and transcriptional arrest within the gene. In both cases, the prediction would be that nascent transcripts should be detectable in nuclear run-on assays. However, measuring the elongation rate of MCP-1 in our experimental system, TNF-a exposure only induced chemokine transcription in non-tumorigenic cells, while no nascent MCP-1 transcript formation could be visualized both in tumorigenic segregants (Figure 2 ) and parental HeLa cells (not shown). This corroborates the assumption that the MCP-1 gene is regulated at the level of initiation of transcription.
The examination of the nucleosomal structure of the MCP-1 gene revealed not only dierences in the distribution, but also in the extension of a major nuclease-hypersensitive site in non-tumorigenic cells (Figure 3a) . This property could be further supported by the higher accessibility of DraI, whose recognition site is located close to a functional AP-1 binding site (Ueda et al., 1994) (Figure 4a , see also Figure 6 for DNA sequence analysis). In contrast, the ApaI cleavage site, which is situated approximately 50 and 80 bp upstream of two NF-kB binding sites (see Figure  6 ), showed roughly an equal susceptibility, which was not further enhanced after TNF-a addition (Figure 4b) . It is therefore reasonable to assume that resistance to DraI in`CGL3' cells may re¯ect the inability of AP-1 to bind to its cognate recognition site at position 72276/72270. Conversely, the chromatin is presumably open for the transcription factor NF-kB, since both DHSRs were equally susceptible for ApaI digestion.
Furthermore, an additional minor proximal DHSR (5.1 kb upstream of KpnI recognition site) could be mapped, being present only in those cells, where MCP-1 gene expression can be induced (Figures 3 and 4) . Another minor hypersensitive region was found within the distal 1.5 kb fragment (Figure 3a ). Scanning these particular regions after cloning from chromosome 17-speci®c cosmids and DNA sequencing for cis-regulatory elements, two potential binding sites for the ubiquitous transcription factor Sp1 were detected ( Figure 6 ). However, previous Western blot analyses showed no quantitative dierences in Sp1 expression levels in tumorigenic and non-tumorigenic HPV 18-positive cells (Maehama et al., 1998) , rendering it unlikely that Sp1 is involved in the dierential regulation of MCP-1 in our experimental cell system. Other potential binding sites were detected for the transcription factor NF-IL-6 (C/EBP-b) within the minor 5'-and 3'-sensitive region as well as in the major 3'-DHSRs (see Figure 6 for sequence analysis). Although the ectopic expression of C/EBP-b confers lipopolysaccharide-inducible MCP-1 transcription in certain cell lines (Bretz et al., 1994) , selected oligonucleotides containing such putative sequence stretches did not show any reproducible C/EBP-b signal retardation in electrophoretic band-shift assays (data not shown). If there is an involvement of C/EBPb in MCP-1 regulation, then it is probably only indirectly by protein ± protein interaction with the transcription factor NF-kB (Stein et al., 1993) .
The ®nding of an additional, TNF-a inducible 3'-DHSR ( Figure 5 ) led to the assumption that selective expression of the MCP-1 gene in non-tumorigenic cells can only be achieved in cooperation between dierent transcription factors interacting both with the 5'-promoter region and cis-regulatory sequences at the 3'-end. Beside the pre-existing 5'-DHSRs, which were only slightly increased by cytokine treatment (Figures 3  and 4) , TNF-a has to further open the 3'-chromatin structure in such a way that transcription factors such as AP-1 can bind to its cognate recognition site 5'-TGAGTCA-3' at position +2594/+2600, located approximately 600 bp downstream of the MCP-1 speci®c polyadenylation signal ( Figure 5 ). Hence, an appropriate nucleosomal structure is probably also the reason why transient transfections of CAT-reporter constructs harboring both the 5'-and 3'-regulatory stretches of the MCP-1 gene failed to show any signi®cant dierences in TNF-a inducibility in non-malignant cells (data not shown). Whether this re¯ects the existence of additional intragenic regulatory elements remains to be elucidated.
The importance of potential 3'-regulatory-sequences has been also stressed for the rodent MCP-1 gene (Freter et al., 1992) . Here, a 7-mer (5'-TTTTGTA-3'), which is located between the stop codon of the third exon and the polyadenylation signal, was found to be required for full gene induction by serum or PDGF. It will be of particular interest to study whether cognate sequences detected within the 3'-DHSR (e.g. 5'-TTTTATA-3' at positions +2741 ± 2748 and 5'-TTTTAAG-3' between positions 2937 and 2943) have similar function in the selective TNF-a inducibility of the human MCP-1 gene in`444'-cells.
Since the human type I collagenase gene (Oringa et al., 1990) followed exactly the same expression pattern as shown for the MCP-1 mRNA (compare Figure 1a and 8b), it seems likely that the transcription factor AP-1 and in particular its dimerization pattern represents a central key event in the overall transcriptional regulation of this particular gene. This can be deduced from the observation that both genes were expressed and became TNF-a inducible only in those cells (see Figure 1a and 8b), where c-jun (and other members of the jun-family such as junB and junD) were mainly heterodimerized with the fos-related protein fra-1 (Soto et al., 1999) . Conversely, both MCP-1 and the collagenase gene were transcriptionally silent in tumorigenic cells, where the 1 : 1 jun/fra-1 ratio was disturbed (Figure 8a ). It should be noted that exactly the same results were obtained in parental HeLa cells, indicating that the dierences in chromatin structure and AP-1 composition were not a pecularity of intraspeci®c somatic cell hybrids cells but rather correlated with the tumorigenic phenotype of HPV 18-positive cells (Soto et al., 1999) . Moreover, the importance of AP-1 composition in MCP-1 regulation was recently con®rmed in stable transfection experiments using non-malignant`444'-cells as recipients. Here, ectopical expression of the c-fos gene induces tumor formation in nude mice. Analysing the AP-1 composition in such transfectants, the jun/fra-1 ratio was altered in favor to jun/fos heterodimers. Interestingly, changes in AP-1 composition was accompanied by a complete abrogation of the expression and inducibility of the MCP-1 gene (Soto et al., 1999) .
On the other hand, transient over-expression of the fra-1 gene alone or in combinations with c-jun was not sucient to induce the MCP-1 expression in tumorigenic`CGL3' or HeLa cells (data not shown). This may either re¯ect the importance of a balanced stoichiometry of dierent jun/fos-family members in building up functional AP-1 complexes and/or might be due to dierences in the phosphorylation pattern cjun, known to control the half-life of c-fos (Tsurumi et al., 1995; Soto et al., 1999) . Nevertheless, in order to further substantiate a functional correlation between AP-1 composition and chemokine expression, MCP-1 positive A 172 glioblastoma cells (Ueda et al., 1994 (Ueda et al., , 1997 were examined. Using this particular cell system as an additional control, jun-proteins (e.g. c-jun) were again preferentially associated with fra-1, while c-fos was absent (data not shown).
These results suggest that a particular AP-1 composition as well as an appropriate chromatin structure at both ends of the gene represent an essential prerequisite for dierential regulation of MCP-1 expression in non-tumorigenic versus tumorigenic HPV-positive cells.
Materials and methods

Cell lines
HPV 18-positive cervical carcinoma cells (HeLa), nontumorigenic somatic cell hybrids made between HeLa cells and normal human ®broblasts (`444'), the corresponding tumorigenic segregants (`CGL3') (Stanbridge, 1984) and the human glioblastoma cell line A172 were maintained in Dulbecco's modi®ed Eagle's medium, supplemented with 10% fetal calf serum, 1% penicillin/streptomycin.
Cytokines and reagents
For cytokine treatment, the cells were incubated with TNF-a (speci®c activity: 1610 8 units/mg) (Pharma Biotechnologie, Hannover, Germany) for dierent periods of time as described in the Figure legends. Cycloheximide (Sigma, St. Louise, USA) was stored as a 10 mg/ml stock solutions at 7208C.
RNA analysis
Total cellular RNA was extracted according to the guanidineum-thiocyanate procedure (Chomczynski and Sacchi, 1987) . Approximately 5 mg of total cellular RNA was separated on 1% agarose gels as described elsewere .
Quantification of apoptosis
The rate of apoptosis was determined a Cell Death Detection ELISA PLUS Kit (Roche) as recommended by the manufacturer. The enrichment factor was calculated by setting the absorbance of the untreated cells as 1.
Isolation and DNA sequence analysis of the human MCP-1 gene A chromosome 17 speci®c cosmid library was screened using the cDNA of MCP-1 as a probe. The sequence of thē anking genomic regions was ®nally determined using two plasmid clones harboring overlapping inserts of about 7.7 kb (a KpnI-KpnI-fragment for the 5'-region) and a 4.7 kb (HindIII-HindIII-fragment for intron/exon and the 3'-region) in size. DNA sequence analysis was done on both strands using chemically synthesized primers and¯uorescent sequencing on an automatic sequencer (Model 377, Perkin-Elmer/ Applied Biosystems) and the dye terminator method according to the manufacturers protocol (`ABI PRISM Big Dye Ready Reaction Terminator Cycle Sequencing Kit', Perkin-Elmer/Applied Biosystems). Putative binding sites for transcription factors were identi®ed by the computer program Transfac version 3.3' (Wingender et al., 1997) . The complete 11793 bp sequence of the human MCP-1 gene locus encompassing the 5' and 3'-regulatory region as well as the introns is available at the EMBL nucleotide sequence data base (accession number: Y18933).
RNA and DNA probes
HPV 18 represent the unit-length of HPV 18 DNA cloned in pBR322 (Boshart et al., 1984) . pHFA1 (Gunning et al., 1983) , containing an approximately full-length insert of the ®broblast b-actin gene was a generous gift from L Kedes (Medical Center, Palo Alto, USA). The full-length cDNA encoding the monocyte-chemoattractant-protein-1 (MCP-1) (Rollins et al., 1989) was obtained from the American Type Culture Collection (Rockville, MD, USA). The cDNA of the human type I collagenase gene (Oringa et al., 1990) was kindly provided by P Angel (Deutsches Krebsforschungszentrum). The PCR product encompassing parts of the MCP-1 promotor ranges from 7539 to +52 according to (Ueda et al., 1994) was ampli®ed and subcloned as described previously .
SDS ± PAGE and Western blotting
Cellular extracts (Dignam et al., 1983) were separated in sodium dodecyl sulfate (SDS) 12% polyacrylamide gels (PAGE), electrotransferred to PVDF membranes (Immobilon-P, Millipore Corporation Bedford, MA, USA), and probed with polyclonal rabbit IkB-a antibodies (epitope corresponding to the amino acids 297 ± 317 mapping at the carboxy terminus, Santa Cruz Biotechnology, CA, USA) as described recently (Soto et al., 1999) . Equal protein transfer and loading was routinously monitored by incubating identical ®lters with a monoclonal b-actin speci®c antibody (ICN Biomedicals, OH, USA).
Nuclear run-on assays
Nuclei from exponentially growing cells were prepared as described recently (Maehama et al., 1998) . Heat-denaturated linearized DNA fragments were ®xed onto nitrocellulose ®lters using the S+S minifold II slot apparatus (Schleicher and Schuell, Germany) and hybridized with equal amounts 32 P-labeled RNA. After 48 h, the ®lters were washes with 26SSC/0.1% SDS at 688C.
Isolation of nuclei and nuclease digestion conditions for chromatin analysis
Nuclei from HeLa,`CGL3' and`444'-cells were prepared (RoÈ sl et al., 1989 ) and digested with as described in the Figure legends . Southern blot analyses were done using standard protocols.
Electrophoretic mobility shift assays
To analyse protein/DNA interactions by electrophoretic mobility shift assays (EMSAs), the following oligonucleotides were used: the AP-1 binding site (5'-GGAAGGTTGAGT-CAAGGGATT-3') located within the DNAse I hypersensitive site downstream of the MCP-1 gene (position +2587/ +2607), an AP-1 consensus sequence, 5@-CGCTTGAT-GACTCAGCCGGAA-3' (Lee et al., 1987) , an oligonucleotide containing a recognition site for the nuclear factor 1 (NF-1) derived from the Adenovirus origin, 5'-TTTTGGATTGAAGCCAATATGATAA-3' (Kenny and Hurwitz, 1988) . The DNAs were synthesized using a phosphoramitide chemistry (Applied Biosystems synthesizer) and further puri®ed by HPLC. Preparation of nuclear extracts, electrophoretic mobility shift and supershift assays were performed exactly as described (Soto et al., 1999) .
